T F Baumert - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T F Baumert

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Journal of Virology|May 3, 2001

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virusJ Köck, M Nassal, S MacNelly, et al.

Journal of Materials Chemistry. B|April 9, 2020

Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infectionE Crouchet, R Saad, C Affolter-Zbaraszczuk, et al.

Journal of Virology|November 17, 2001

Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sitesA Fournillier, C Wychowski, D Boucreux, et al.

Gastroenterology|December 2, 1999

Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidateT F Baumert, J Vergalla, J Satoi, et al.

Gastroenterologie Clinique Et Biologique|May 10, 2008

[Neutralizing antibodies in hepatitis C virus infection]S Fafi-Kremer, M B Zeisel, E Schvoerer, et al.

The Journal of General Virology|October 18, 2015

Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factorsL W Meredith, K Hu, X Cheng, et al.

Hepatology (Baltimore, Md.)|August 29, 2000

Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis CT F Baumert, S Wellnitz, S Aono, et al.

Gene Therapy|November 14, 2014

Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-conceptC Leboeuf, J Roser-Schilder, M Lambotin, et al.

Journal of Viral Hepatitis|June 3, 2009

Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantationI M V G C Mello, C Thumann, E Schvoerer, et al.

Pathologie-Biologie|October 10, 2008

[Study of hepatitis C virus leukotropism by characterization of viral quasispecies in the liver transplantation setting]F Schramm, R Moenne-Loccoz, S Fafi-Kremer, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Journal of Virology|May 3, 2001

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virusJ Köck, M Nassal, S MacNelly, et al.

Journal of Materials Chemistry. B|April 9, 2020

Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infectionE Crouchet, R Saad, C Affolter-Zbaraszczuk, et al.

Journal of Virology|November 17, 2001

Induction of hepatitis C virus E1 envelope protein-specific immune response can be enhanced by mutation of N-glycosylation sitesA Fournillier, C Wychowski, D Boucreux, et al.

Gastroenterology|December 2, 1999

Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidateT F Baumert, J Vergalla, J Satoi, et al.

Gastroenterologie Clinique Et Biologique|May 10, 2008

[Neutralizing antibodies in hepatitis C virus infection]S Fafi-Kremer, M B Zeisel, E Schvoerer, et al.

The Journal of General Virology|October 18, 2015

Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factorsL W Meredith, K Hu, X Cheng, et al.

Hepatology (Baltimore, Md.)|August 29, 2000

Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis CT F Baumert, S Wellnitz, S Aono, et al.

Gene Therapy|November 14, 2014

Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-conceptC Leboeuf, J Roser-Schilder, M Lambotin, et al.

Journal of Viral Hepatitis|June 3, 2009

Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantationI M V G C Mello, C Thumann, E Schvoerer, et al.

Pathologie-Biologie|October 10, 2008

[Study of hepatitis C virus leukotropism by characterization of viral quasispecies in the liver transplantation setting]F Schramm, R Moenne-Loccoz, S Fafi-Kremer, et al.

Pageof 2